Oncolytic virus-based combination therapy in breast cancer

Bahreyni, Amirhossein; Mohamud, Yasir; Luo, Honglin

doi:10.1016/j.canlet.2024.216634

Cancer Letters

2024

DOI: 10.1016/j.canlet.2024.216634

|View full text |Cite

Oncolytic virus-based combination therapy in breast cancer

Amirhossein Bahreyni,

Yasir Mohamud,

Honglin Luo

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article5

Relationship

Self Cite0

Independent5

Authors

Journals

Cited by 10 publications

References 86 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Light‐Enhanced Tandem‐Responsive Nano Delivery Platform for Amplified Anti‐tumor Efficiency

Wang,

Li,

2024

Chemistry An Asian Journal

View full text Add to dashboard Cite

Designing nanomedicines with low toxicity, high targeting, excellent therapeutic effects, and precise release is always the major challenges in clinical cancer treatment. Here, we report a light‐enhanced tandem‐responsive nano delivery platform COF‐B@X‐03 for amplified anti‐tumor efficiency. Biotin‐loaded COF‐B@X‐03 could precisely target tumor cells, and the azo and hydrazone bonds in it would be depolymerized by the overexpressed azoreductase and acidic microenvironment in hypoxic tumors. In vitro experimental results indicate mitochondrial and endoplasmic reticulum stress caused by COF‐B@X‐03 under light is the direct cause of tumor cell death. In vivo experimental data prove COF‐B@X‐03 achieves low oxygen dependent phototherapy, and the maintenance of intratumoral hypoxia provides the possibility for the continuous degradation of COF‐B@X‐03 to generate more reactive oxygen species for tumor photodynamic therapy by released X‐03. In the end, COF‐B@X‐03 phototherapy group achieves higher tumor inhibition rate than X‐03 phototherapy group, which is 81.37%. Meanwhile, COF‐B@X‐03 significantly eliminates the risk of tumor metastasis. In summary, the construction of this tandem‐responsive nano delivery platform provides a new direction for achieving efficient removal of solid tumors in clinical practice.

show abstract

Light‐Enhanced Tandem‐Responsive Nano Delivery Platform for Amplified Anti‐tumor Efficiency

Wang,

Li,

2024

Chemistry An Asian Journal

View full text Add to dashboard Cite

show abstract

Recent advances in biomimetic strategies for the immunotherapy of glioblastoma

You,

Geng,

et al. 2024

Biomaterials

View full text Add to dashboard Cite

Tuning cellular metabolism for cancer virotherapy

Xiong,

Wang,

Wang

et al. 2024

Cancer Letters

View full text Add to dashboard Cite

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Oncolytic virus-based combination therapy in breast cancer

Cited by 10 publications

References 86 publications

Light‐Enhanced Tandem‐Responsive Nano Delivery Platform for Amplified Anti‐tumor Efficiency

Light‐Enhanced Tandem‐Responsive Nano Delivery Platform for Amplified Anti‐tumor Efficiency

Recent advances in biomimetic strategies for the immunotherapy of glioblastoma

Tuning cellular metabolism for cancer virotherapy

Contact Info

Product

Resources

About